Abstract
Photodynamic therapy (PDT) is an emerging treatment modality for cancer as well as non-cancer diseases. PDT involves administration of a photosensitizer in targeted tissues and photogeneration of cytotoxic reactive oxygen species that destroys tumor cells. Much effort has been paid to disperse hydrophobic photosensitizers molecularly in water, since self-aggregation of photosensitizers significantly reduces singlet oxygen yield. The self-aggregation and the particle formation have, however, been revaluated and extended in terms of passive tumor cell targeting and ongoing nanotechnology. Upon systemic administration, nanoparticles are preferentially taken up by tumor tissues due to EPR effect (Enhanced Permeability and Retention Effect). To improve therapeutic efficacy and suppress side effects, a variety of approaches has been explored by using photosensitizer nanoparticles such as dendrimers, quantum dots, liposomes, polymer micelles, peptide-conjugates, and hydrogel nanoparticles. Control of the size, surface property, and amphiphilicity are key factors in optimizing the nano-PDT-agents. In this article, the author will review recent progress in this growing field, including our approaches, from the viewpoint of supramolecular chemistry and nanotechnology. Future subjects will also be discussed.
Keywords: Semiconductor quantum dots, MRI technique, dendrimer, liposomes, PLGA micelles
Current Bioactive Compounds
Title: Photosensitizer Nanoparticles for Photodynamic Therapy
Volume: 3 Issue: 4
Author(s): Toru Oba
Affiliation:
Keywords: Semiconductor quantum dots, MRI technique, dendrimer, liposomes, PLGA micelles
Abstract: Photodynamic therapy (PDT) is an emerging treatment modality for cancer as well as non-cancer diseases. PDT involves administration of a photosensitizer in targeted tissues and photogeneration of cytotoxic reactive oxygen species that destroys tumor cells. Much effort has been paid to disperse hydrophobic photosensitizers molecularly in water, since self-aggregation of photosensitizers significantly reduces singlet oxygen yield. The self-aggregation and the particle formation have, however, been revaluated and extended in terms of passive tumor cell targeting and ongoing nanotechnology. Upon systemic administration, nanoparticles are preferentially taken up by tumor tissues due to EPR effect (Enhanced Permeability and Retention Effect). To improve therapeutic efficacy and suppress side effects, a variety of approaches has been explored by using photosensitizer nanoparticles such as dendrimers, quantum dots, liposomes, polymer micelles, peptide-conjugates, and hydrogel nanoparticles. Control of the size, surface property, and amphiphilicity are key factors in optimizing the nano-PDT-agents. In this article, the author will review recent progress in this growing field, including our approaches, from the viewpoint of supramolecular chemistry and nanotechnology. Future subjects will also be discussed.
Export Options
About this article
Cite this article as:
Oba Toru, Photosensitizer Nanoparticles for Photodynamic Therapy, Current Bioactive Compounds 2007; 3 (4) . https://dx.doi.org/10.2174/157340707783220248
DOI https://dx.doi.org/10.2174/157340707783220248 |
Print ISSN 1573-4072 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6646 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Tubulin-Independent Tau in Alzheimer’s Disease and Cancer: Implications for Disease Pathogenesis and Treatment
Current Alzheimer Research Nucleic Acid-Based Aptamers: Applications, Development and Clinical Trials
Current Medicinal Chemistry Cell-Penetrating Peptides: Mechanisms and Applications
Current Pharmaceutical Design G4 Aptamers: Trends in Structural Design
Mini-Reviews in Medicinal Chemistry Retinal Ganglion Cell Gene Therapy and Visual System Repair
Current Gene Therapy HPV Viral Activity by mRNA-HPV Molecular Analysis to Screen the Transforming Infections in Precancer Cervical Lesions
Current Pharmaceutical Biotechnology Butyrate and Colorectal Cancer: The Role of Butyrate Transport
Current Drug Metabolism Gene Therapy Approaches for the Prevention of Restenosis
Current Vascular Pharmacology Mechanisms and Inhibitors of Apoptosis in Cardiovascular Diseases
Current Pharmaceutical Design Stemness or Not Stemness? Current Status and Perspectives of Adult Retinal Stem Cells
Current Stem Cell Research & Therapy Viral Carcinogenesis of Oral Region and Recent Trends in Treatment
Recent Patents on Biomarkers Cyclin-Dependent Kinase Inhibition by Flavoalkaloids
Mini-Reviews in Medicinal Chemistry Targeting Hormonal Signaling Pathways in Castration Resistant Prostate Cancer
Recent Patents on Anti-Cancer Drug Discovery Chromatin Remodeling Agents for Cancer Therapy
Reviews on Recent Clinical Trials Combined Treatment with PPAR-γ Agonists in Pancreatic Cancer: A Glimmer of Hope for Cancer Therapy?
Current Cancer Drug Targets MicroRNA-7 Regulates Insulin Signaling Pathway by Targeting IRS1, IRS2, and RAF1 Genes in Gestational Diabetes Mellitus
MicroRNA Cancer: A Problem of Developmental Biology; Scientific Evidence for Reprogramming and Differentiation Therapy
Current Drug Targets Metastasis Suppressors: Basic and Translational Advances
Current Pharmaceutical Biotechnology Subject Index to Volume 3
Current Medicinal Chemistry - Anti-Cancer Agents The MYCN Oncogene as a Specific and Selective Drug Target for Peripheral and Central Nervous System Tumors
Current Cancer Drug Targets